No Data
No Data
The innovative drug sector fluctuated higher. Alice rose and stopped at 20CM, Sansheng Guojian rose more than 10%, and Tiger Pharmaceuticals, Changshan Pharmaceutical, Fuxiang Pharmaceutical, and Shenzhou Cell registered higher gains.
The innovative drug sector fluctuated higher. Alice rose and stopped at 20CM, Sansheng Guojian rose more than 10%, and Tiger Pharmaceuticals, Changshan Pharmaceutical, Fuxiang Pharmaceutical, and Shenzhou Cell registered higher gains.
Dragon Tiger List丨Changshan Pharmaceutical's 20cm rise and closed the list with a net purchase of 107 million yuan
Gelonghui, April 25 | Changshan Pharmaceutical (300255.SZ) rose or stopped 20cm today, with a turnover of 530 million yuan and a turnover rate of 4.94%. According to data from the Dragon Tiger List, the “leisure group” sold five seats, with a net sale of 1987.75 million yuan. The listed seats bought 139 million yuan throughout the day and sold 32.2642 million yuan, for a total net purchase of 107 million yuan.
Effenatide was accepted, and Changshan Pharmaceutical welcomed another “20cm” increase and stop. Company: It's not about diet pills!
The same “recipe”
The concept of diet pills strengthened in early trading, and Changshan Pharmaceutical rose and stopped
The concept of diet pills strengthened in early trading, Changshan Pharmaceutical went up and down, while Boji Pharmaceutical, Hanyu Pharmaceutical, Baihua Pharmaceutical, Watson Pharmaceuticals, and Borui Pharmaceuticals followed suit.
Express News | Changshan Pharmaceutical: Application for marketing license for ebennatide injection accepted
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutica
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutical, Shuyu Pingmin, Changshan Pharmaceutical, and Dian Diagnosis fell more than 3%.
No Data